Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Private equity radiology investor reaches agreement with FTC over alleged anticompetitive tactics
US Radiology Specialists backer Welsh, Carson, Anderson & Stowe blasted the proposed order Friday, labeling it as symbolic and politically motivated.
Congressional candidate physician sues hospital and doctor for death of father
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
DEA wants to permanently anchor some COVID-era prescription regulations
The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.
FDA regulator examines AI's growing influence in cardiology
Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.
RadNet sees potential midsize and larger acquisitions on its horizon
Leaders with the Los Angeles-based, publicly traded imaging center operator spoke Jan. 15 at the 43rd annual JP Morgan Healthcare Conference in San Francisco.

American College of Radiology, nuclear medicine society urge CMS to fix years-old billing code mistakes

SNMMI and ACR are pushing the agency to make modifications retroactive, so specialists can still claim lost revenues impacted by the error.

FDA warning letter: iRhythm committed multiple violations, failed to report patient deaths in time

“It is your firm’s responsibility to ensure compliance with applicable laws and regulations administered by FDA,” according to the warning letter. These issues, the agency added, “may be symptomatic of serious problems in your firm’s manufacturing and quality management systems.”

Philips' latest collaboration could make xenon MR imaging more widely available

In alliance with Polarean, Philips is rolling out a new MR system with advanced multi-nuclei imaging capabilities that will offer radiologists a detailed evaluation of lung ventilation using xenon gas as a contrast agent.

Startup scores FDA clearance for virtual reality tool that creates patient avatars via CT, MR images

Avatar Medical said its VR solution can serve as an aid in pre-operative planning or for use during procedures.

S&P downgrades Radiology Partners amid worries its capital structure could become unsustainable

The country's largest imaging group has $3.37B in obligations, including “significant debt maturities looming in July 2025.”

Merck Januvia Janumet Steglujan Nitroso-STG-19 (NTTP) type 2 diabetes

Merck sues US government over Medicare's drug price negotiation liberties, calls program a 'sham'

Merck believes the Inflation Reduction Act-launched effort “coerces” manufacturers to enter into agreements to sell their top products at a fraction of their actual value.

Incorrect place-of-service codes resulted in Medicare overpayments totaling in the millions

The audit revealed that Medicare overpaid by approximately $22.5 million due to incorrect place-of-service coding completed by practitioners.

Conformal Medical raises $35M to continue development, research of next-gen LAAO device

The new investments were announced as the company continues developing its CLAAS device for sealing the LAA during LAAO procedures.

Management

Private equity radiology investor reaches agreement with FTC over alleged anticompetitive tactics

Congressional candidate physician sues hospital and doctor for death of father

DEA wants to permanently anchor some COVID-era prescription regulations

FDA regulator examines AI's growing influence in cardiology

RadNet sees potential midsize and larger acquisitions on its horizon